Switching to ORLADEYO
People who switched to
ORLADEYO® from an injectable
preventative treatment consistently
saw success in controlling attacks
![](https://orladeyo.kinsta.cloud/wp-content/uploads/kurtis-quote.png?v65)
— Kurtis, switched to ORLADEYO in 2021
Individual results may vary
![Kurtis, a real person with hereditary angioedema (HAE) that takes ORLADEYO®](https://orladeyo.kinsta.cloud/wp-content/uploads/patient-kurtis.jpg?vs)
![People with HAE who have switched to ORLADEYO® had 98% attack-free days](https://orladeyo.kinsta.cloud/wp-content/uploads/patient-calendar-98.png?v)
In a study, people who switched from an injectable
preventative treatment to ORLADEYO enjoyed
In a study, people taking ORLADEYO
![](https://orladeyo.kinsta.cloud/wp-content/uploads/kurtis-98-days.png)
![People with HAE who have switched to ORLADEYO® had 98% attack-free days](https://orladeyo.kinsta.cloud/wp-content/uploads/kurtis-98-days.png?v)
after switching from an injectable preventative treatmenta
During the study, treatment satisfaction scores generally increased across the treatment satisfaction questionnaire for medication (TSQM) in those who switched to ORLADEYO.
aThese data are from an analysis of 34 US patients who switched from an injectable preventative treatment to ORLADEYO during a long-term safety study. It is unknown what attack rates would have been for these patients had they remained on their previous treatment.
People are switching to—and staying on—ORLADEYO, all because it’s meeting their expectations
Start the conversation with your healthcare provider about joining more than 2,500 others who have been prescribed ORLADEYO
Download the discussion guide and use it to talk to your healthcare provider about where you are in your journey, your satisfaction with your current treatment plan, and if ORLADEYO may be right for you.
Le‘ah is talking about why she made the move to ORLADEYO
Hear her story.
Ready to get started?
Le‘ah is talking about why she made the move to ORLADEYO
Hear her story.
Ready to get started?